50 results
8-K
AUPH
Aurinia Pharmaceuticals Inc
14 Jun 24
Submission of Matters to a Vote of Security Holders
5:25pm
of the Compensation Committee, and Member of the Audit Committee; R. Hector MacKay-Dunn, J.D., K.C., Director, Chair of the Governance & Nomination Committee
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
– Suite 700 Rockville, MD 20850 USA governance practices and, if followed by shareholders, could result in a public company without oversight … serious about his proposals or experienced in corporate governance best practices, he would provide specificity and actionable steps. In addition, Aurinia
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
the holistic approach the Company takes to address environmental, social and governance priorities, including energy and emissions, addressing
8-K
EX-10.1
u42o3t7
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
zi7je902r28hdz
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
nwj3g7iq
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
8-K
EX-99.1
pguumxweyh dng68
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
PX14A6G
1k6p6 tqxdr
26 Apr 23
Letter to shareholders
10:20am
DEFA14A
23w71 l42g8pa
18 Apr 22
Additional proxy soliciting materials
7:36am
DEF 14A
px8jbiuxkr tw2n658
10 May 21
Definitive proxy
4:06pm
PRE 14A
q90htm
27 Apr 21
Preliminary proxy
4:32pm
10-K
95nlrfbcuf2e
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
rwcl2tckqtau0a63sh
30 Dec 20
Material Change Report
5:30pm